Home > Income Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Consolidated Net Profit

    Back to Income Statement
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹-326 Cr₹91 Cr₹18 Cr₹-186 Cr₹376 Cr

What is the latest Consolidated Net Profit of PIRAMAL PHARMA ?

The latest Consolidated Net Profit ratio of PIRAMAL PHARMA is ₹-326 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹-326 Cr
Mar2025₹91 Cr
Mar2024₹18 Cr
Mar2023₹-186 Cr
Mar2022₹376 Cr

How is Consolidated Net Profit of PIRAMAL PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹-326 Cr
Negative
Mar2025 ₹91 Cr
411.39
Mar2024 ₹18 Cr
Positive
Mar2023 ₹-186 Cr
Negative
Mar2022 ₹376 Cr -

Compare Consolidated Net Profit of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹22,885.0 Cr -2.3% 1.8% -17.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,195.0 Cr 1.8% 9% 12.5% Stock Analytics
DIVIS LABORATORIES ₹180,823.0 Cr 0.8% 0.8% -1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹165,725.0 Cr 2.8% 9.5% 45.4% Stock Analytics
CIPLA ₹116,467.0 Cr -1.2% 4.7% -4.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,987.0 Cr -7.6% 0.1% 6.1% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-2.3%

1.8%

-17.7%

SENSEX

-1%

4.4%

-8.3%


You may also like the below Video Courses